Legal Representation
Attorney
Rosemary S. Tarlton
USPTO Deadlines
Application History
10 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 23, 2009 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Mar 23, 2009 | MAB6 | O | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Aug 19, 2008 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| May 27, 2008 | PUBO | A | PUBLISHED FOR OPPOSITION |
| May 7, 2008 | NPUB | O | NOTICE OF PUBLICATION |
| Apr 22, 2008 | ALIE | A | ASSIGNED TO LIE |
| Apr 22, 2008 | PREV | O | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Apr 17, 2008 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Apr 7, 2008 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 10, 2008 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceuticals, namely, implantable drug delivery system comprised primarily of sustained release drugs for the treatment of central nervous system disorders, cancer and other serious and life-threatening diseases
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
USPTO Documents
Click to view cached USPTO documents for this trademark
Only administrators can request new documents from USPTO